Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions

J Med Chem. 1999 Oct 7;42(20):4225-31. doi: 10.1021/jm990224w.

Abstract

Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridine (tacrine) unit were constructed in an effort to further delineate structural requirements for optimal binding to the AChE peripheral site. Basic amines of differing hydrophobicity were selected as peripheral site ligands, and in each case, improvements in inhibitory potency and selectivity were seen relative to tacrine itself. AChE IC(50) values of the optimum dimers decrease significantly as the peripheral site ligand was permuted in the series ammonia > dimethylamine > 4-aminopyridine > 4-aminoquinoline > tacrine. Calculated desolvation free energies of the optimum dimers match the trend in IC(50) values, suggesting the importance of ligand hydrophobicity for effective cation-pi interaction with the peripheral site.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Butyrylcholinesterase / metabolism
  • Cholinesterase Inhibitors / chemical synthesis*
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / metabolism
  • Cholinesterase Inhibitors / pharmacology
  • Crystallography, X-Ray
  • Drug Design
  • In Vitro Techniques
  • Ligands
  • Protein Binding
  • Rats
  • Structure-Activity Relationship
  • Tacrine / analogs & derivatives*
  • Tacrine / chemical synthesis*
  • Tacrine / chemistry
  • Tacrine / pharmacology

Substances

  • Cholinesterase Inhibitors
  • Ligands
  • Tacrine
  • Acetylcholinesterase
  • Butyrylcholinesterase